Insiders who reported open-market trades in the last 12 months at the companies Gregory R. Friberg files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
George Eric Davis - $2.76M in BMRN purchases and sales in the last 12 months
Charles Greg Guyer - $997K in BMRN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Gregory R. Friberg is a corporate insider, tracked as EVP, Chief R&D Officer of BIOMARIN PHARMACEUTICAL INC (BMRN). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Gregory R. Friberg submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Gregory R. Friberg been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($559K) across all tracked filings.
Gregory R. Friberg is EVP, Chief R&D Officer of BIOMARIN PHARMACEUTICAL INC (BMRN). 6 SEC Form 4 filings on record going back to 2024, most recently on 1 October 2026. Most recent open-market trade: sold $177K of BMRN on 11 May 2026. Lifetime open-market sales: $559K.
Recent transactions
8
The latest 8 SEC Form 4 transactions reported by Gregory R. Friberg.
InsiderAlpha's records for Gregory R. Friberg go back to 2024: 6 primary Form 4 filings, an average of 2.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
